Presentation TCT 2022 TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance Presenter: Alejandro Gutierrez-Barrios September 19, 2022 REGISTER for free or LOG IN to view this content Coronary TCT 2022 Up Next Presentation TCT 2022 TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison Presenter: Tijn Jansen September 19, 2022 More slides + Presentation TCT 2022 TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan Presenter: Shinichiro Masuda September 19, 2022 Presentation TCT 2022 TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial. Presenter: Tijn Jansen September 19, 2022 We Recommend
Presentation TCT 2022 TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison Presenter: Tijn Jansen September 19, 2022
Presentation TCT 2022 TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan Presenter: Shinichiro Masuda September 19, 2022
Presentation TCT 2022 TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial. Presenter: Tijn Jansen September 19, 2022